Evaluation Of Clinically Selected Patients (Pts) With Advanced Non-Small Cell Lung Cancer (Nsclc) Recruited In China In A Phase Iii, Randomized, Open-Label, First-Line Study In Asia Of Gefitinib (G) Versus Carboplatin/Paclitaxel (C/P) (Ipass)